Paradromics’ brain implant gears up for human trials in 2025
CNBC - 21-Jun-2024Novel brain implant technology aimed at helping patients with speech loss
Join the club for FREE to access the whole archive and other member benefits.
Founder and CEO of Paradromics
Matt Angle is the founder and CEO of Paradromics. He has a technical background in the design of neural recording systems, and he is an active advocate for neurotechnology as medicine.
Matt completed his PhD in Neuroscience at the Max Planck Institute for Medical Research at the University of Heidelberg. Prior to founding Paradromics in 2015, Matt conducted postdoctoral research in the Department of Materials Science and Engineering at Stanford University focused on next-gen electronics for large-scale neural recordings.
Visit website: https://www.paradromics.com/about#MattAngle
See also: Paradromics - Brain Computer Interfaces
Details last updated 01-Jul-2024
Novel brain implant technology aimed at helping patients with speech loss